References
- Accardo A, Salsano G, Morisco A, et al. (2012). Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent. Int J Nanomedicine 7:2007–17
- Alzouebi M, Goepel JR, Horsman JM, Hancock BW. (2012). Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol 40:2075–80
- Cabeza L, Ortiz R, Arias JL, et al. (2015). Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles. Int J Nanomedicine 10:1291–306
- Castillo J, Winer E, Quesenberry P. (2008). Newer monoclonal antibodies for hematological malignancies. Exp Hematol 36:755–68
- Chen WC, Completo GC, Sigal DS, et al. (2010). In vivo targeting of B-cell lymphoma with glycan ligands of CD22. Blood 115:4778–86
- Davis T, Farag SS. (2013). Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine. Int J Nanomedicine 8:3479–88
- Duan Y, Wang J, Yang X, et al. (2015). Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro. Drug Deliv 22:50–7
- Han Y, Li Y, Zhang P, et al. (2015). Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy. Pharm Dev Technol . [Epub ahead of print]. doi: 10.3109/10837450.2014.996900
- Han Y, Zhang Y, Li D, et al. (2014). Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomedicine 9:4107–16
- Hashimoto Y, Shimizu T, Abu Lila AS, et al. (2015). Relationship between the Concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice. Biol Pharm Bull 38:417–24
- Hejri A, Khosravi A, Gharanjig K, Hejazi M. (2013). Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method. Food Chem 141:117–23
- Keereweer S, Mol IM, Kerrebijn JD, et al. (2012). Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer. J Surg Oncol 105:714–18
- Li M, Tang Z, Zhang D, et al. (2015). Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models. Biomaterials 51:161–72
- Momoh MA, Kenechukwu FC, Attama AA. (2013). Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride. Drug Deliv 20:102–11
- Namvar F, Rahman HS, Mohamad R, et al. (2015). Cytotoxic effects of biosynthesized zinc oxide nanoparticles on murine cell lines. Evid Based Complement Alternat Med 2015:593014
- Prabhu RH, Patravale VB, Joshi MD. (2015). Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine 10:1001–18
- Sabattini E, Bacci F, Sagramoso C, Pileri SA. (2010). WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica 102:83–7
- Setaro F, Brasch M, Hahn U, et al. (2015). Generation-dependent templated self-assembly of biohybrid protein nanoparticles around photosensitizer dendrimers. Nano Lett 15:1245–51
- Shao Z, Shao J, Tan B, et al. (2015). Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA. Int J Nanomedicine 10:1223–33
- Thakkar A, Chenreddy S, Wang J, Prabhu S. (2015). Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention. Int J Oncol 46:1827–34
- Vighi E, Montanari M, Ruozi B, et al. (2012). The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier. Drug Deliv 19:1–10
- Wang J, Jia J, Liu J, et al. (2013). Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins. Drug Deliv 20:356–63
- Wang J, Xia Q. (2014). Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitro. Drug Deliv 21:328–41
- Wang L, Li X, Liu X, et al. (2015). Enhancing effects of indirubin on the arsenic disulfide-induced apoptosis of human diffuse large B-cell lymphoma cells. Oncol Lett 9:1940–6
- Wang Y, Dou L, He H, et al. (2014). Multifunctional nanoparticles as nanocarrier for vincristine sulfate delivery to overcome tumor multidrug resistance. Mol Pharm 11:885–94
- Xiao K, Luo J, Li Y, et al. (2011). PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma. J Control Release 155:272–81
- Xu W, Cui Y, Ling P, Li LB. (2012). Preparation and evaluation of folate-modified cationic pluronic micelles for poorly soluble anticancer drug. Drug Deliv 19:208–19
- Xu Z, Chen L, Gu W, et al. (2009). The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 30:226–32
- Yang S, Damiano MG, Zhang H, et al. (2013). Biomimetic, synthetic HDL nanostructures for lymphoma. Proc Natl Acad Sci USA 110:2511–16
- Yuan L, Liu C, Chen Y, et al. (2013). Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model. Int J Nanomedicine 8:4339–50
- Zanotto-Filho A, Braganhol E, Klafke K, et al. (2015). Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. Cancer Lett 358:220–31